Prospectus

The Institute of Good Manufacturing Practices India, an autonomous Institute recognised by Ministry of Commerce & Industry, accredited Vocational Institution of Ministry of Education, Government of India and approved by Food Safety and Standards Authority of India (FSSAI), presents a unique, friendly and interactive platform to get rid of all your GMP compliance related issues. GMP—an essential element of industries like pharmaceutical, cosmetic, Ayurveda, biotech, homeopathic, medical device and food manufacturing and sustainability services—in itself is the most dynamic part which witnesses frequent changes in terms of new rules being added and old ones being renewed. Thus, keeping oneself updated with current GMPs is essential to remain aligned with evolving industry requirement and standards.

Our team comprises knowledgeable professionals from diverse sectors such as Pharma, Healthcare, Food, Nutraceutical, and Nutrition industries, pooling together their expertise, know-how, and experiences to create this GMP guide. IGMPI is moving hand in hand with technology advances and has gained recognition as a stronger and better education and training platform provider for professionals and students in the areas of GMP, Quality Assurance and Control, Pharma, Food & Nutrition, Environment and Healthcare Regulatory Affairs, Clinical Research, Pharmaceutical IPR, Good Laboratory Practice and Product Management. Keeping pace with the digital era, IGMPI has also expanded into the domains of Geoinformatics, Remote Sensing, Cybersecurity, Information Security, and Network Security, preparing learners to address the growing need for secure and resilient information systems as well as advanced geospatial solutions.

Our board of governors and specialists have collated their acumen and are offering state-of-the-art courses which include GMP training, Quality Assurance and Control, Pharma and healthcare Regulatory Affairs, Clinical Research, Pharmaceutical IPR, Environment Social Governance (ESG), Good Laboratory Practice, Information Security Compliance and Remote Sensing. These are delivered in the form of formal classroom studies, online/interactive programmes, online seminars, and onsite training programmes, along with insights into global industry practices. In short, a round-the-clock service is provided for any information in these areas required by anybody from around the country and abroad.

Based on high standards of quality, the training programmes in Pharma, Healthcare and Food GMP, Quality Assurance and Quality Control, Regulatory Affairs, IPR, Pharma Product Management, Public Health, Hospital Management, Clinical Research, Pharmacovigilance, Medical Writing, Medical Coding, Nanotechnology, Drug Design and Discovery, Food QA&QC have been approved by the Quality Council of India, which is an autonomous body and an accreditation authority for education & vocational training providers under the Ministry of Commerce & Industry, Government of India. IGMPI is duly licensed and certified by Bureau of Indian Standards (BIS) under Bureau of Indian Standards (Conformity Assessment) Regulations 2018.

The Post Graduate and Executive Diploma programmes of IGMPI in Good Manufacturing Practices, Regulatory Affairs, Intellectual Property Rights, Quality Assurance and Quality Control, Public Health, Nanotechnology, Hospital Management, Product Management, Sales and Marketing Management, Clinical Research, Medical Writing, Drug Discovery and Development, Pharmacovigilance, Medical Coding have been duly assessed and approved by Quality Council of India, Government of India based on fulfillment of QCI's following criteria:

    1. Course Content
    2. Course Design
    3. Course Material
    4. Instructors
    5. Class size & Attendance
    6. Facilities
    7. Evaluation of Students
    8. Written Examination
    9. Certificate

IGMPI is also approved by Food Safety and Standards Authority of India (FSSAI) (FSSAI ID: TPINS18). IGMPI® is licensed by Department of Food Safety & Drug Administration under the Drugs and Cosmetics Act, 1940 and registered under Food Safety and Standards Act 2006.

IGMPI is also approved by Sector Skills Council under National Skill Development Corporation (NSDC) setup by Ministry of Skill Development & Entrepreneurship, Govt of India (TC ID:TC342267).

IGMPI has been conferred with the prestigious "BUREAU OF INDIAN STANDARDS (BIS) AWARD OF HONOUR 2023". QUALITY COUNCIL OF INDIA (QCI) has also conferred IGMPI with D.L. SHAH NATIONAL QUALITY AWARD, Certificate of Merit & ASSOCHAM has conferred IGMPI with the Services Excellence Award based on excellence of its services to the students and training participants.

Bureau of Indian Standards (BIS) is a member of International Organization for Standardization (ISO) and through the Indian National Committee (INC) which is a member of International Electrotechnical Commission (IEC). BIS is also a member of regional standards bodies like Pacific Area Standards Congress (PASC) and South Asian Regional Standards Organization (SARSO). India started taking part in IEC from 1911 and subsequently the then Indian Standards Institution (now BIS) took over the responsibility of Indian National Committee of IEC(INC-IEC) in 1949. Since then the INC-IEC is actively participating in the activities of the IEC both at the policy level and technical work and carrying out the responsibilities as member body of IEC Council. India is a member in Standards Management Board (SMB) of IEC since 2015.BIS has also signed Bilateral Cooperation Agreements (BCA)/Mutual Recognition Agreements (MRA) with the National Standards Bodies of several countries like Afghanistan, Bangladesh, Belarus, Egypt, European Union , Germany, Ghana, Greece, Indonesia, Iran, Japan, Jordon, Kenya, Kyrgyzstan, Mali, Mauritius, Nigeria, Russia, Saudi Arabia , Slovakia, Slovenia, Suriname, USA, UAE, Uzbekistan, Viet Nam, Bhutan, Brazil, Israel, Nepal, Pakistan and Sri Lanka.

National Accreditation Board for Certification Bodies (NABCB), Quality Council of India is a member of International Accreditation Forum (IAF) & Pacific Accreditation Cooperation (PAC) as well as signatory to its MLAs for Quality Management Systems, Environmental Management Systems and Product Certification. NABCB is also a Full Member of International Laboratory Accreditation Cooperation (ILAC) & Asia Pacific Laboratory Accreditation Cooperation (APLAC) as well as signatory to its MRAs for Inspection.

The field of medical genomics is transforming modern healthcare by enabling precision medicine, where disease prevention, diagnosis, prognosis, and treatment are guided by an individual's genetic profile. Rapid advances in next-generation sequencing (NGS), bioinformatics, artificial intelligence, and molecular diagnostics have revolutionised the understanding of inherited and acquired diseases, creating an increasing demand for professionals with expertise in genomic technologies and clinical genomics.

The Post Graduate Diploma/Executive Diploma in Medical Genomics (PGMG/EMG) is designed to provide comprehensive knowledge of human genetics, genomic technologies, bioinformatics, variant analysis, clinical genomics, pharmacogenomics, precision oncology, and multi-omics approaches. The programme covers the complete genomic workflow, including sequencing technologies, bioinformatics pipelines, variant annotation and interpretation, clinical reporting, ethical and regulatory considerations, and the application of genomics in personalised medicine.

The curriculum integrates scientific principles with industry-oriented applications, enabling participants to develop competencies in genomic data analysis, molecular diagnostics, clinical interpretation, and precision medicine. Through case studies and contemporary genomic tools, participants will gain the knowledge required to contribute effectively to clinical practice, biomedical research, and the rapidly evolving genomics industry.

Programme Modules

International Affiliation with

Module 1. Introduction to Medical Genomics

• Human Genome Project
• Human genome organization
• Gene structure and regulation
• Chromosomes and karyotyping
• Mendelian and complex disorders
• Principles of precision medicine

Module 2. Human Genetic Variation

• Human genetics
• Types of Genetic Variants
• Functional Consequences
• Somatic mutations 

Module 3. Genomic Technologies

• Classical Techniques
• Array Technologies
• Next Generation Sequencing
• RNA Sequencing
• Single Cell Sequencing
• Spatial Transcriptomics
• Liquid Biopsy 

Module 4. NGS Platforms

• Illumina
• Ion Torrent
• Oxford Nanopore
• PacBio SMRT
• BGI/MGI sequencing
• Platform comparison 

Module 5. NGS Bioinformatics Pipeline

• Bioinformatics pipelines
• Germline Variant Calling
• Somatic Variant Calling
• Structural Variant Calling
• CNV Detection
• Fusion Detection 

Module 6. Variant Annotation

• Annotation tools
• Population databases
• Disease databases
• Cancer databases
• Protein databases
• Genome browsers 

Module 7. Variant Interpretation

• ACMG/AMP Guidelines
• Variant Classification: Pathogenic, Likely pathogenic, VUS, Likely benign, Benign
• Evidence: Population frequency, Computational prediction, Functional evidence, Segregation, Literature, Clinical evidence
• In silico prediction: SIFT, PolyPhen-2 , CADD, REVEL, MutationTaster, SpliceAI ,Alpha Missense 

Module 8. Clinical Genomics

• Rare diseases
• Prenatal genetics
• Carrier screening
• Newborn screening
• Cardiovascular genetics
• Neurogenetics
• Inherited metabolic disorders
• Pharmacogenomics

Module 9. Precision Oncology

• Companion diagnostics
• Tumour mutation burden
• Microsatellite instability
• Homologous recombination deficiency
• Minimal residual disease
• Liquid biopsy
• Actionable biomarkers 

Module 10. Pharmacogenomics

• Drug-gene interactions
• CPIC guidelines
• DPWG guidelines
• Genes: CYP2D6, CYP2C19, TPMT, UGT1A1, DPYD, HLA-B, SLCO1B1, VKORC1
• Clinical implementation 

Module 11. Multiomics

• Genomics
• Transcriptomics
• Proteomics
• Metabolomics
• Epigenomics
• Radiogenomics 

Module 12. Artificial Intelligence in Genomics

• Machine Learning
• Deep Learning
• Variant prioritization
• Pathogenicity prediction
• Clinical decision support

Module 13. Clinical Reporting

• Interpretation workflow
• Report structure
• Secondary findings
• Incidental findings
• Genetic counseling
• Family screening
• Clinical recommendations 

Module 14. Ethical, Legal and Regulatory Issues

• Consent and Privacy, Data security
• GDPR
• Data sharing
• GA4GH
• Genetic discrimination
• Clinical accreditation
• ISO 15189 

Module 15. Case Studies

Module 16: Capstone Project

Eligibility

Graduates in any discipline are eligible for our Post Graduate Diploma, Executive Diploma and Professional Certifications Programmes. 10+2 pass-outs are eligible for our Under Graduate Diploma and Diploma holders of two to three years course duration are also eligible for the PG Diploma.

Programme Duration

The minimum duration to complete the PG diploma programme is 12 months and maximum is 24 months. The minimum duration to complete the executive diploma programme is 6 months and maximum is 12 months.

Programme Mode

Registrations are currently open for regular and Part-time (Online Live Classes) both modes.

Programme Deliverables

A comprehensive study material for all the modules in hard copies ensuring the needs of the audience. The accompanying training material is appropriately aligned with the current Industry’s expectations.

• Assignments for all the programme modules for continuous evaluation and guidance.
• Interactive or online live sessions on all key areas of the programme giving all flexibility to the participants.
• Part-time (Online Live Classes) for all the modules will be conducted on the weekends. Moreover, a doubt clearing session will also be scheduled before the examination.
• All the efforts are made by IGMPI faculty members to make the entire programme modules easily understandable.
• Assessment and evaluation for all the programme modules in order to enhance the levels of competencies and skills of the participants leading towards the objective of application in the job.
• At the end of each programme modules, the trainers shall obtain feedback from the participants using specially designed questionnaires.
• All learning and training delivery initiatives shall be conducted in English.

Examination & Certification

All the participants are expected to appear for an online exam and are also obliged to submit assignments after each module. After successful completion, the participants will be awarded Post Graduate Diploma/Executive Diploma in Medical Genomics (PGMG/EMG)

 by IGMPI. For all the above-mentioned modules, Part-time (Online Live Classes) or face-to-face classes (Regular mode), elaborate programme material, self-assessment assignments would be provided by the Institute. Details get updated on the webpage as well.

Discipline in Classes and Examination

Every student is required to observe a disciplined behaviour during her/his classes, assessments & examinations and to follow instructions from the Professors. Any act of indiscipline may result into discredit & it will be mentioned in her/his academic report.

Placement Assistance & Corporate Relations

The Institute has partnered with many organizations for providing with placement assistance to its participants. Besides, it has a robust placement cell comprised of senior level Human Resources professionals and Talent Acquisition experts which maintains close links with business and industry. This cell is continuously engaged in promoting the employability of our participants and encouraging the concerned Human Resources department and Hiring Managers to recruit/hire our participants for their vacant positions. The efforts of our placement cell also include helping with professional resume writing & interview skills.

In recent months the Institute has witnessed more and more participation from professionals working with global pharmaceutical, healthcare like Johnson & Johnson, Roche, Novartis, Merck & Co., AbbVie, GlaxoSmithKline, Pfizer, Sanofi, Bayer, Eli Lilly & Co., Novo Nordisk, Teva Pharmaceutical Industries, Dr. Reddy’s Laboratories, Lupin Limited, Torrent Pharmaceutical Ltd., Cipla Limited, Emcure Pharmaceuticals, Sun Pharmaceutical Limited, Mankind Pharma, Ajanta Pharma, IPCA Laboratories etc. The IGMPI’s Corporate ResourceDivision actively recommends our students and training participants for various jobrequirements and specialized roles to Human Resource, Talent Acquisition as well as the headsof various departments in Pharmaceutical, Healthcare industries on regular basis.

Future Prospects from an Industry Perspective

The global healthcare and life sciences industry is undergoing a paradigm shift from conventional medicine to precision medicine, creating an unprecedented demand for professionals skilled in medical genomics, next-generation sequencing (NGS), bioinformatics, and genomic data interpretation. The rapid adoption of genomic technologies by hospitals, molecular diagnostic laboratories, biotechnology and pharmaceutical companies, contract research organizations (CROs), companion diagnostics manufacturers, and digital health companies has significantly expanded career opportunities in this field. Advances in cancer genomics, rare disease diagnostics, pharmacogenomics, reproductive genetics, infectious disease genomics, and population genomics have made genomic expertise an essential component of modern healthcare and biomedical innovation.

This course is designed to bridge the gap between academic knowledge and industry requirements by providing students with practical competencies in sequencing technologies, bioinformatics pipelines, variant calling and interpretation, clinical reporting, quality management, and regulatory standards. Graduates will be prepared for roles in molecular diagnostics, clinical genomics, bioinformatics, genomic data analysis, biomarker discovery, precision oncology, pharmacogenomics, companion diagnostics, scientific affairs, regulatory affairs, clinical research, and medical writing. The curriculum also aligns with the increasing demand for professionals capable of integrating artificial intelligence, machine learning, and multi-omics data into clinical and pharmaceutical decision-making.

As pharmaceutical and biotechnology industries continue to invest in targeted therapies, biomarker-driven clinical trials, gene therapies, and personalized medicines, professionals with expertise in medical genomics are becoming integral to drug discovery, translational research, clinical development, and diagnostic innovation. Consequently, graduates of this course will possess industry-relevant knowledge and practical skills that are highly valued across healthcare, biotechnology, pharmaceutical, diagnostics, and precision medicine sectors, positioning them for long-term career growth in one of the fastest-expanding areas of modern biomedical science.